Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-25 @ 1:27 AM
NCT ID:
NCT01524094
Eligibility Criteria:
Inclusion Criteria:
* Metastatic disease to the peritoneum from colon or rectum (at least two isolated sites of disease)
* verified primary tumor of adenocarcinoma of the colon or rectum
* Potential resectability as judged by the treating surgeon
* Patient is available for follow-up according to the study protocol
* Signed informed consent
Exclusion Criteria:
* Extraabdominal metastases or liver metastases
* Paraaortic or other inoperable lymph node metastases
* Clear indication for surgery only (such as obstruction, bleeding or peritonitis)
* Prior treatment of either arm in the study
* Clinical or histopathological diagnosis of Peritoneal Pseudomyxoma
* Age \> 80
* Contraindications for chemotherapy
* Pregnancy or breastfeeding
* Ongoing infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01524094
Study Brief:
Protocol Section:
NCT01524094